At Novo Nordisk Capital Markets Day, Co U.S. Head Says Novo Has Gained Roughly 8 Share Points In Obesity Since January; 50% Of Entire Wegovy Franchise And 90% Of Wegovy Pill U.S. Sales Now In Self-Pay Channel
https://edge.media-server.com/mmc/p/xdjeyf7u/
Share
Why It Matters
Novo Nordisk is selling more obesity medicine without insurance. This shows people really want their weight loss drugs.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.